| Mrs Johnney Mae Morris, LPN | |
|
4893 Pine Ridge Dr W, Bushkill, PA 18324-8433 | |
| (570) 793-8703 | |
| Not Available |
| Full Name | Mrs Johnney Mae Morris |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 4893 Pine Ridge Dr W, Bushkill, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700379211 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 315745 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Johnney Mae Morris, LPN 4893 Pine Ridge Dr W, Bushkill, PA 18324-8433 Ph: () - | Mrs Johnney Mae Morris, LPN 4893 Pine Ridge Dr W, Bushkill, PA 18324-8433 Ph: (570) 793-8703 |
News Archive
During early childhood, girls with autism tend to show greater reduction and less rise in their autism symptom severity than boys with autism, a UC Davis MIND Institute study has found.
HIT Application Solutions, a leading healthcare technology development company, announced today the company has raised $2.75 M USD in its Series A funding effort.
In a study published online yesterday focused on the medical products industry - which includes medical devices, pharmaceuticals and biologics - a group of researchers found that, compared to firms with all-male boards, firms with female directors announced high-severity product recalls 28 days sooner.
Treasury Secretary Jack Lew said Monday the nation will hit its debt limit in mid-October, setting up a potential clash between the White House and some House Republicans who say they will tie their votes on raising the debt ceiling to defunding the health law. Also in the news, a survey of business economists cites future deficits as the nation's most pressing problem, which will be exacerbated by aging baby boomers reliant on Social Security and Medicare.
Updated data from the ongoing AURA study of AZD9291 shows encouraging, although still immature, median progression free survival of 9.6 months (95% CI 8.3 to NC) in patients with epidermal growth factor receptor mutation positive (EGFRm) T790M+ advanced non-small cell lung cancer (NSCLC) who had disease progression following treatment with an EGFR tyrosine kinase inhibitor (EGFR TKI).
› Verified 1 days ago
Patience Asante-odame, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 433 Ranchlands, Bushkill, PA 18324 Phone: 845-517-7470 |